Streamlining Dermatology Imaging Prior Auth

Klivira automates the complex process of dermatology imaging prior auth, ensuring timely approvals for critical diagnostic procedures related to advanced skin conditions and cancers.

For revenue cycle directors and prior authorization coordinators in dermatology, managing imaging PA presents unique challenges. While biologics and Mohs surgery are primary PA triggers, advanced imaging like MRI, CT, and PET are increasingly critical for staging advanced skin cancers, evaluating complex infections, or pre-surgical planning. These orders often route through specialized radiology benefit managers (RBMs), adding layers of complexity.

The Intersection of Dermatology and Imaging Prior Auth

Dermatology practices frequently require advanced imaging for diagnosing and staging conditions beyond routine skin exams. This includes comprehensive assessments for advanced melanoma, Merkel cell carcinoma, deep tissue infections, or complex pre-surgical evaluations. Ensuring these imaging orders receive timely prior authorization, often from entities like eviCore, NIA Magellan, or Carelon Medical Benefits Management (formerly AIM Specialty Health), is crucial for patient care and revenue integrity.

Common Imaging Scenarios in Dermatology Requiring Prior Authorization

MRI for tumor staging, recurrence, or assessment of soft tissue involvement in complex skin cancers.
CT scans to evaluate lymphatic spread or distant metastases in advanced melanoma or squamous cell carcinoma.
PET scans for identifying metastatic disease in high-risk melanomas or other aggressive skin malignancies.
Advanced Ultrasound for regional lymph node assessment or guiding biopsies.
Bone scans to detect skeletal metastases from aggressive skin cancers.

Navigating Radiology Benefit Managers (RBMs) in Dermatology

Many commercial payers delegate advanced imaging prior authorization to RBMs such as eviCore, NIA Magellan, and Carelon Medical Benefits Management. These vendors apply rigorous medical necessity criteria, predominantly based on ACR Appropriateness Criteria, to evaluate imaging requests. Klivira's platform is engineered to identify the correct RBM automatically and submit comprehensive clinical documentation from the EMR, minimizing manual effort and reducing submission errors.

Klivira's Automated Approach to Dermatology Imaging PA

Klivira integrates seamlessly with your EMR, leveraging CDS Hooks (e.g., 'order-sign' events for ServiceRequest) to detect advanced imaging orders at the point of care. Our system automatically identifies the responsible payer and routes the request to the correct destination—be it payer-direct via X12 278 or Da Vinci PAS, or to a specific RBM portal. This proactive detection and routing eliminate missed PAs and vendor identification errors common in manual workflows.

Key Documentation for Dermatology Imaging PA Success

Precise ICD-10 diagnosis codes for specific skin cancers or dermatological conditions requiring imaging.
Detailed tumor staging information and clinical question for the requested imaging.
History of prior treatments, including surgeries, radiation, or systemic therapies.
Documentation of conservative care trials, if applicable to the condition being imaged.
Alignment with ACR Appropriateness Criteria, which Klivira can pre-check before submission.

Streamlining the Dermatology Imaging PA Workflow

By automating dermatology imaging prior authorization, Klivira reduces administrative burden, accelerates approval times, and improves patient throughput. Our platform performs pre-submission checks against ACR Appropriateness Criteria, offering alternative imaging recommendations at order entry to prevent denials. For clinical denials, an integrated peer-to-peer workflow simplifies scheduling, ensuring that dermatologists can focus on patient care rather than administrative overhead.

Frequently asked questions

How does Klivira handle imaging PA for advanced skin cancer staging ordered by a dermatologist?

Klivira's platform integrates with your EMR to detect advanced imaging orders for conditions like melanoma or Merkel cell carcinoma. It then automatically routes the request to the correct payer or RBM (e.g., eviCore, NIA Magellan), populating the submission with relevant clinical data like tumor staging and prior treatments, aligned with NCCN guidelines and ACR Appropriateness Criteria.

Which specific RBMs does Klivira integrate with for dermatology imaging orders?

Klivira maintains direct integrations with major radiology benefit managers, including eviCore, NIA Magellan, and Carelon Medical Benefits Management (formerly AIM Specialty Health). This ensures that imaging prior authorization requests originating from dermatology practices are accurately routed and submitted according to each RBM's specific requirements.

Can Klivira help dermatologists meet ACR Appropriateness Criteria for imaging requests?

Yes, Klivira incorporates ACR Appropriateness Criteria into its pre-submission checks. When an imaging order is placed, the system evaluates it against these criteria and can surface recommendations for alternative imaging or additional documentation, helping dermatologists ensure their requests meet medical necessity guidelines before submission, reducing denial rates.

What EMR touchpoints are involved when a dermatologist orders imaging with Klivira?

Klivira leverages SMART on FHIR and CDS Hooks to integrate directly into the EMR workflow. When a dermatologist places an advanced imaging order (e.g., a ServiceRequest), Klivira is triggered at the 'order-sign' event, initiating the automated PA process by pulling relevant patient and clinical data directly from the EMR.

How does Klivira manage peer-to-peer reviews for dermatology imaging denials?

For imaging orders denied on clinical appropriateness grounds, Klivira provides an integrated workflow to facilitate peer-to-peer reviews. Our platform streamlines the scheduling and documentation required for these discussions with RBM or payer medical directors, ensuring that dermatologists can efficiently advocate for their patients' imaging needs.